- Report
- August 2022
- 30 Pages
Global
From €2958EUR$3,250USD£2,536GBP
Masitinib is a tyrosine kinase inhibitor used in the treatment of certain types of cancer in animals. It is used to treat mast cell tumors in dogs, and is also used to treat certain types of lymphoma in cats. Masitinib is a prescription drug, and is available in tablet form. It is administered orally, and is typically given once or twice daily.
Masitinib is a relatively new drug in the animal pharmaceuticals market, and is gaining popularity due to its effectiveness in treating certain types of cancer. It is generally well-tolerated by animals, and has fewer side effects than some other cancer treatments.
Companies in the Masitinib market include AB Science, VetDC, and Elanco Animal Health. Show Less Read more